VivoSeq
Other

Suprascapular Nerve Block

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Suprascapular Nerve Block is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Completed4 · 67%
Unknown status1 · 17%
Recruiting1 · 17%

Clinical Trials

Trial Activity

6 trials

Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis
Recruiting·CCHU de Reims·N/A·NCT06176248·62 enrolled
Peng Block or Suprascapular Nerve Block for Postoperative Analgesia in Shoulder Artroscopy ?
Completed·—·N/A·NCT05666076·74 enrolled
Suprascapular Nerve Block as Postoperative Analgesia After Artroscopic Shoulder Surgery
Completed·KKai Henrik Wiborg Lange·N/A·NCT02576223·40 enrolled
The Effect of Dexmedetomidine for Suprascapular Nerve Block With Axillary Nerve Block
Completed·—·Phase 4·NCT04398589·46 enrolled
Quality of Life and Pain With Infiltration or Suprascapular Nerve Block in Glenohumeral Arthirtis
Completed·IInstituto Mexicano del Seguro Social·Phase 3·NCT03794505·40 enrolled
Postoperative Analgesia of Magnesium Sulfate in Suprascapular Nerve Block Following Shoulder Arthroscopy
Unknown status·MMansoura University·N/A·NCT03602469·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)